TMO - Thermo Fisher Scientific, Inc. -  [ ]

Ticker Details
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $185.98B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.12 | 1.00%
Avg Daily Range (30 D): $6.43 | 1.31%
Avg Daily Range (90 D): $6.44 | 1.19%
Institutional Daily Volume
Avg Daily Volume: 1.83M
Avg Daily Volume (30 D): 1.54M
Avg Daily Volume (90 D): 1.69M
Trade Size
Avg Trade Size (Sh.): 91
Avg Trade Size (Sh.) (30 D): 26
Avg Trade Size (Sh.) (90 D): 28
Institutional Trades
Total Institutional Trades: 38,409
Avg Institutional Trade: $11.67M
Avg Institutional Trade (30 D): $40.55M
Avg Institutional Trade (90 D): $40.65M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 6
Market Closing Trades
Avg Closing Trade: $54.56M
Avg Closing Trade (30 D): $150.38M
Avg Closing Trade (90 D): $156.15M
Avg Closing Volume: 168.79K
 
News
Apr 10, 2026 @ 2:40 PM
The Market Is Selling Everything, but These 5 Stoc...
Source: Bridget Bennett
Apr 10, 2026 @ 9:45 AM
Global Next-Generation Sequencing (NGS) Market to ...
Source: Researchandmarkets.Com
Apr 9, 2026 @ 8:49 AM
Biopharmaceutical Third Party Logistics (Distribut...
Source: Researchandmarkets.Com
Apr 7, 2026 @ 5:44 PM
Global DNA Read, Write and Edit Market to Surge to...
Source: Bcc Research
Apr 6, 2026 @ 6:00 PM
Global Validation, Calibration and Standardization...
Source: Bcc Research
Financials
  TTM Q4 2025 FY 2025
Basic EPS $17.77 $5.22 $17.77
Diluted EPS $17.74 $5.21 $17.74
Revenue $44.56B $12.22B $44.56B
Gross Profit
Net Income / Loss $6.72B $1.97B $6.72B
Operating Income / Loss $7.75B $2.26B $7.75B
Cost of Revenue
Net Cash Flow $5.57B $7.87B $5.57B
PE Ratio 27.97